HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.
Meeting News CoverageVideo

VIDEO: Nicotinamide may reduce risk for basal, squamous cell carcinoma

March 18, 2016
NEW YORK — Martin A. Weinstock, MD, PhD, professor of dermatology and community health at Brown University, discussed effective…
Meeting News Coverage

Experts debate role of completion lymphadenectomy for node-positive melanoma

March 18, 2016
NEW YORK — Two speakers debated whether completion lymphadenectomy is still standard of care for patients with sentinel lymph-node positive…
Meeting News CoverageVideo

VIDEO: Speaker reviews evolving roles of screening, surveillance for melanoma

March 18, 2016
NEW YORK — Allen C. Halpern, MD, MsC, chief of dermatology at Memorial Sloan Kettering Cancer Center, discussed the current state of screening…
Meeting News Coverage

Longer surgical interval shortens RFS when residual melanoma is present

March 18, 2016
NEW YORK — Longer surgical interval following initial biopsy may worsen RFS outcomes in patients with residual melanoma, according to a…
Meeting News Coverage

Talimogene laherparepvec, pembrolizumab combination safely treats advanced melanoma

March 18, 2016
NEW YORK — Patients with advanced unresectable melanoma can safely receive combination therapy with full doses of talimogene laherparepvec and…
Meeting News Coverage

Surgery after immunotherapy may extend OS in patients with metastatic melanoma

March 18, 2016
NEW YORK — Complete metastasectomy after high-dose interleukin-2 therapy may prolong OS in patients with metastatic melanoma, according to…
Meeting News Coverage

HemOnc Today Melanoma and Cutaneous Malignancies spotlights advances in detection, treatment

March 16, 2016
The staff of HemOnc Today and Healio.com/HemOnc will present live coverage from HemOnc Today Melanoma and Cutaneous Malignancies, scheduled for…
Meeting News Coverage

Next-generation sequencing increases actionable mutation detection in malignant melanoma

April 26, 2015
NEW YORK — The use of next-generation sequencing in multi-gene targeted panel testing identified a considerable number of actionable mutations…
Meeting News Coverage

Durable response to T-VEC, GM-CSF linked to longer OS

April 25, 2015
NEW YORK — Patients with unresected stage IIIB, stage IIIc or stage IV melanoma who achieved durable response to either talimogene…
Meeting News Coverage

T-VEC plus ipilimumab appears safe, effective for unresected melanoma

April 23, 2015
NEW YORK — Talimogene laherparepvec combined with ipilimumab demonstrated tolerability at the planned doses without dose-limiting toxicities in…